METHDILAZINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Methdilazine Hydrochloride patents expire, and what generic alternatives are available?
Methdilazine Hydrochloride is a drug marketed by Alpharma Us Pharms and is included in one NDA.
The generic ingredient in METHDILAZINE HYDROCHLORIDE is methdilazine hydrochloride. There are four drug master file entries for this compound. Additional details are available on the methdilazine hydrochloride profile page.
Summary for METHDILAZINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 41 |
Patent Applications: | 224 |
Formulation / Manufacturing: | see details |
DailyMed Link: | METHDILAZINE HYDROCHLORIDE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for METHDILAZINE HYDROCHLORIDE
US Patents and Regulatory Information for METHDILAZINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alpharma Us Pharms | METHDILAZINE HYDROCHLORIDE | methdilazine hydrochloride | SYRUP;ORAL | 087122-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |